| HCV | Hepatitis C |
| RBV | Ribavirin |
| PrOD | Paritaprevir/ritonavir/ombitasvir/dasabuvir |
| CAP | Controlled attenuation parameter |
| SVR | Sustained virologic response |
| LDL-C | Low-density lipoprotein cholesterol |
| HOMA-IR | Homeostatic model assessment—insulin resistance |
| HCC | Hepatocellular carcinoma |
| VLDL | Very-low-density lipoprotein |
| TG | Triglycerides |
| HDL-C | High-density lipoprotein cholesterol |
| DAA | Direct acting antivirals |
| RNA | Ribonucleic acid |
| REB | Research Ethics Board |
| kPa | Kilopascal |
| BMI | Body mass index |
| IFN | Interferon |
| HbA1c | Glycated hemoglobin |
| LVP | Lipo-viral particles |